LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

NeuroOne Medical Technologies Corporation

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERNMTC
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / NMTC COVERAGE

What’s moving NeuroOne Medical Technologies Corporation now

Current reporting with the operating signal separated from the noise.

01
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q2 2025 Earnings Call Transcript

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q2 2025 Earnings Call Transcript

Investors are testing whether NeuroOne Medical Technologies Corporation’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

Investors are testing whether NeuroOne Medical Technologies Corporation’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
NeuroOne Medical Technologies Corporation (NMTC) Q1 2025 Earnings Call Transcript

NeuroOne Medical Technologies Corporation (NMTC) Q1 2025 Earnings Call Transcript

Investors are testing whether NeuroOne Medical Technologies Corporation’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
NeuroOne Medical Technologies Corporation Announces Virtual Investor Webinar to Overview Business Model and Fiscal Year 2025 Revenue Projections

NeuroOne Medical Technologies Corporation Announces Virtual Investor Webinar to Overview Business Model and Fiscal Year 2025 Revenue Projections

Investors are testing whether NeuroOne Medical Technologies Corporation’s operating performance supports its strategy and valuation.

Watch next: official volume, pricing, inventory and segment margin.
05
NeuroOne Medical Technologies Corporation Announces Virtual Roadshow to Discuss Business Model and Revenue Growth Forecast for Fiscal Year 2025

NeuroOne Medical Technologies Corporation Announces Virtual Roadshow to Discuss Business Model and Revenue Growth Forecast for Fiscal Year 2025

Investors are testing whether NeuroOne Medical Technologies Corporation’s operating performance supports its strategy and valuation.

Watch next: official volume, pricing, inventory and segment margin.
PRIMARY DOCUMENTS / SEC EDGAR

Latest NMTC filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-Q/AQuarterly financial reportFiled 2026-06-12 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2026-05-12 · Period 2026-03-31SEC ↗10-K/AAnnual financial reportFiled 2026-01-23 · Period 2025-09-30SEC ↗8-KMaterial company eventFiled 2026-06-12 · Period 2026-06-12SEC ↗8-KMaterial company eventFiled 2026-05-22 · Period 2026-05-21SEC ↗8-KMaterial company eventFiled 2026-05-12 · Period 2026-05-12SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-03-09 · Period 2026-04-03SEC ↗SCHEDULE 13G/AOfficial SEC filingFiled 2026-07-14SEC ↗
EARNINGS / QUARTERLY TRACKER

NeuroOne Medical Technologies Corporation, quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.